Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Information meeting for Swedish actors on European cooperation in cell and gene therapies within precision medicine

Organised by: Vinnova
Digitally Tue 8 Dec 2026 at 10:00-11:00

On December 8, Vinnova is hosting a national information meeting for the call for proposals event titled “European Collaboration on Cell and Gene Therapies in Precision Medicine” as part of the EP PerMed partnership.

This web page has been machine translated. If there are any uncertainties, please refer to the Swedish text.

Who is this meeting intended for?

The meeting is aimed at Swedish actors, including companies, the public sector, and academia, that are interested in applying for funding from Vinnova to participate in a call for proposals in cell and gene therapies through the European Partnership for Precision Medicine (EP PerMed).

Agenda

The meeting is led by Vinnova and describes how Swedish actors goes about applying for funding to ensure Swedish participation in the call for proposals.

  • Information About the EP PerMed Partnership
  • Description of the call for proposals and practical information on how to apply

Participate in the meeting

The meeting takes place digitally via Teams.

Connect to the meeting

In the call for proposals

The European Partnership for Personalized Medicine (EP PerMed) will launch a Call for Proposals (call for proposals) in November 2026 (JTC 2027) focused on developing and validating cell and gene therapies in the field of precision medicine. Vinnova and the Swedish Research Council are funding Swedish participation.

The call for proposals on Vinnova's website

Information on the partnership's website

International information meeting, December 3

Sometimes we photograph or video record our activities. If you don't want to participate in photos or videos, please let us know when you arrive.

Questions?

Casper Ullsten-Wahlund

Utlysningsansvarig

+ 46 8 473 32 06

Last updated 5 November 2026